Loading the records…
Loading the records…
Senator Van Hollen introduced S.4989, the 'Saving Lives and Reducing Health Care Waste by Improving Diagnosis in Medicine Act', which was referred to the HELP Committee on July 15, 2026. The bill authorizes a research program at AHRQ to study diagnostic errors but does not appropriate any funding or mandate private-sector action. At this early stage, the bill has no direct market impact on healthcare companies.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
No market implications at this stage. The bill is an early-stage authorization with no funding, no mandates, and no companion legislation. Healthcare stocks ($DGX, $LH, $GEHC, ) are unaffected. Investors should disregard this bill until it advances through committee or gains a funding mechanism.
On July 15, 2026, Senator Chris Van Hollen (D-MD) introduced S.4989, the 'Saving Lives and Reducing Health Care Waste by Improving Diagnosis in Medicine Act'. The bill was read twice and referred to the Committee on Health, Education, Labor, and Pensions (HELP). It has one original cosponsor, Senator Ben Ray Luján (D-NM). The bill is in an early legislative stage with no committee hearings or markups scheduled.
The bill authorizes the Director of the Agency for Healthcare Research and Quality (AHRQ) to establish a comprehensive program of patient-centered research and quality improvement focused on understanding and reducing diagnostic errors. The program would include research, translation of findings, implementation tools, and stakeholder collaboration. Critically, the bill does not appropriate any specific funding amount — it authorizes a program but leaves actual funding to future appropriations bills. There are no mandates, penalties, or incentives directed at private healthcare companies.
There are no related signals, procurement actions, or presidential actions in the provided data that converge with this bill. The bill is an isolated, early-stage authorization with no companion House bill, no committee action, and no funding attached.
The structural winners from this bill would be the diagnostic testing and imaging companies ($DGX, $LH, $GEHC) and health insurers if the research program eventually leads to guidelines or payment changes that favor their services. However, at this stage, the bill is purely procedural — it creates a research program at a federal agency with no direct private-sector impact. The legislative path requires committee consideration, potential markup, floor votes in both chambers, and a separate appropriations bill to fund the program. Given the 119th Congress is in its second session (2026), the window for passage is narrowing, and the bill faces long odds without significant momentum.
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Authorizes a research and quality improvement program at AHRQ to study diagnostic errors and develop evidence-based strategies; does not mandate specific private-sector actions or allocate direct funding to diagnostic labs.
Who must act
Agency for Healthcare Research and Quality (AHRQ) — a federal agency within HHS.
What happens
AHRQ will conduct and support research on diagnostic errors and best practices; no direct revenue or cost impact on private diagnostic companies.
Stock impact
Quest Diagnostics ($DGX) operates diagnostic testing labs; the bill's research program may eventually inform best practices that affect lab workflows, but no near-term revenue or cost change is mandated.
What the bill does
Same as above — AHRQ research program on diagnostic errors; no direct mandate or funding for LabCorp.
Who must act
AHRQ.
What happens
AHRQ research may produce guidelines that LabCorp could voluntarily adopt; no immediate financial impact.
Stock impact
LabCorp ($LH) is a major diagnostic lab; the bill's research focus on diagnostic errors aligns with industry quality initiatives but imposes no new costs or revenue.
Matched on shared policy language across AI analyses, with ticker & timing weight
A bill to amend title XI of the Social Security Act to establish a payment model to reimburse providers for furnishing comprehensive breast cancer risk assessments and developing personalized screening and risk-reduction plans, and for other purposes.
EVEST Act
To amend title XXVII of the Public Health Service Act and title XIX of the Social Security Act to require coverage of Alzheimer's biomarker testing under group health plans, group and individual health insurance coverage, and the Medicaid program.
Precision Brain Health Research Act of 2026
A bill to modernize and strengthen Federal efforts to improve ovarian cancer awareness, hereditary cancer risk assessment, access to genetic counseling and testing, and access to specialty care, and for other purposes.
ALERT Communities Act
Efficiency Adjustment Delay Act
Women’s Heart Health Expansion Act of 2026
Executive orders & memoranda affecting the same sectors or companies
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →